BDNF and Cognitive impairment: Data from the present study are consistent with previous findings, indicating a reduced hippocampal BDNF level in AD mice, as well as a significant correlation between the BDNF level and the recovery of cognitive deficits (Supplementary Table S1), which further support the use of BDNF treatment as a feasible therapeutic approach in AD.